Lupin gets USFDA nod to market drug used to treat chronic hepatitis B
The company has received tentative approval from the United States Food and Drug Administration (FDA) for its abbreviated new drug application for Tenofovir Alafenamide tablets (25 mg), Lupin said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 18, 2022 Category: Pharmaceuticals Source Type: news
Tenofovir vs. Entecavir Therapy in HBV: Long-term Renal Safety Tenofovir vs. Entecavir Therapy in HBV: Long-term Renal Safety
Do tenofovir and entecavir differ in their long-term impact on renal function in patients with hepatitis B?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 11, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
CDC Recommends Hep B Vaccination for Most Adults CDC Recommends Hep B Vaccination for Most Adults
Faced with an increasing incidence of hepatitis B infection, the Centers for Disease Control and Prevention expanded its vaccination recommendation to include most adults.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - April 2, 2022 Category: Infectious Diseases Tags: Gastroenterology News Source Type: news
Risk for Acute MI Not Increased With Two-Dose HepB-CpG Vaccine
FRIDAY, April 1, 2022 -- The rate of type 1 acute myocardial infarction (MI) is not increased with receipt of the two-dose hepatitis B vaccine with a cytosine phosphoguanine adjuvant (HepB-CpG vaccine) versus the three-dose hepatitis B vaccine with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2022 Category: Pharmaceuticals Source Type: news
Universal HepB Vaccination Recommended for Adults Age 19 to 59
THURSDAY, March 31, 2022 -- Hepatitis B (HepB) vaccination should be administered to adults aged 19 to 59 years and to those aged 60 years or older with risk factors for HepB, according to updated recommendations published in the April 1 issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 31, 2022 Category: Pharmaceuticals Source Type: news
Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022
This report describes updated hepatitis B vaccination recommendations from the Advisory Committee on Immunization Practices. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - March 31, 2022 Category: American Health Tags: Advisory Committee on Immunization Practices (ACIP) Hepatitis B MMWR Morbidity & Mortality Weekly Report Source Type: news
Reassuring Data on Two-Dose Hep B Vaccine, Risk of Acute MI
(MedPage Today) -- There was no higher risk of heart attack for recipients of the two-dose hepatitis B cytosine phosphoguanine adjuvant vaccine (Heplisav-B) compared to the three-dose hepatitis B vaccine with an aluminum hydroxide adjuvant (Engerix... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 28, 2022 Category: Gastroenterology Source Type: news
After patient hospitalized, Peninsula drug developer stops 2nd chronic hepatitis B program this year
The stock of the 93-employee company, which was over $34 a share in the past year, is trading below $3. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 22, 2022 Category: American Health Authors: Ron Leuty Source Type: news
Ghana: Over 200 Vaccinated Against Hepatitis B in Wa Communities
[Ghanaian Times] Wa -- More than 200 people have been vaccinated against Hepatitis B in the last 10 months in six communities in the Wa Municipality and the Wa East District of the Upper West Region. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 18, 2022 Category: African Health Source Type: news
EMA Recommends PreHevbri Hepatitis B Vaccine for Approval EMA Recommends PreHevbri Hepatitis B Vaccine for Approval
The three-antigen hepatitis B vaccine received approval from the FDA in November 2021.International Approvals (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - March 1, 2022 Category: Infectious Diseases Tags: Infectious Diseases News Alert Source Type: news
U.S. FDA Approves CARVYKTI ™ (ciltacabtagene autoleucel), Janssen’s First Cell Therapy, a BCMA-Directed CAR-T Immunotherapy for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
HORSHAM, Pa., February 28, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has approved CARVYKTI™ (ciltacabtagene autoleucel; cilta-cel) for the treatment of adults with relapsed or refractory multiple myeloma (RRMM) after four or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.1 The approval is based on data from the pivotal CARTITUDE-1 study, which included patients who had received a median of six prior treatment regimens (range, 3-18), and had previously rec...
Source: Johnson and Johnson - March 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Role of Gut Microbiota in HBV Disease Progression and Treatment Role of Gut Microbiota in HBV Disease Progression and Treatment
This review aims to clarify our understanding of the pathophysiology of gut microbiota and their relationship with liver injury in chronic hepatitis B. How might this inform future therapeutics?Journal of Viral Hepatitis (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - February 21, 2022 Category: Transplant Surgery Tags: Gastroenterology Journal Article Source Type: news
Dangerous Medicine: The Story Behind Human Experiments with Hepatitis – review
Sydney Halpern ’s account of postwar US research that deliberately infected hundreds with the disease is shocking – and important for the Covid eraFor three decades after the second world war, US scientists and doctors carried out a research programme of striking ambition – and breathtaking moral negligence. They deliberately infected more than 1,000 people, including at least 100 children, with hepatitis, an illness that can trigger chronic liver disease and cancer.Very few of those subjected to this experimentation had much idea of what was being inflicted upon them. Many were poor and uneducated and came from pris...
Source: Guardian Unlimited Science - February 20, 2022 Category: Science Authors: Robin McKie Tags: Science and nature books Culture Hepatitis B Hepatitis C Medical research Source Type: news
ACIP Issues Adult Vaccination Schedule 2022 ACIP Issues Adult Vaccination Schedule 2022
Changes affect zoster, pneumococcal, and hepatitis B vaccines, and COVID-19 is now included.News Alerts (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 17, 2022 Category: Allergy & Immunology Tags: Internal Medicine News Alert Source Type: news
Hep B Testing, Vaccine Seen Cost-Effective in Pregnant Women Hep B Testing, Vaccine Seen Cost-Effective in Pregnant Women
Although vaccination is not routine during pregnancy, guidelines from ACOG state that at-risk women should be screened and vaccinated for hepatitis B during pregnancy.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - February 11, 2022 Category: Infectious Diseases Tags: Ob/Gyn & Women ' s Health News Source Type: news
